News|Articles|February 10, 2023
Scope 2023: Emerging Biopharma Companies
Author(s)Andy Studna, Senior Editor
Murray L. Aitken, SVP of IQVIA speaks about how biopharma companies can take advantage of present opportunities at the SCOPE 2023 conference in Orlando, FL.
Advertisement
In an interview at the 2023 SCOPE conference with ACT editor, Andy Studna, Murray L. Aitken, SVP of IQVIA discusses how biopharma companies can take advantage of present opportunities.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Why Real-World Evidence Can No Longer Wait Until After Approval
2
Three Tensions Transforming Clinical Operations Excellence
3
ACT Brief: Process Architecture Over Autonomous AI, Real-Time RWE Integration, and Building RWE Infrastructure
4
SCOPE X: The COPD Case Study That Shows What AI Can Do for Enrollment
5